UY36813A - USE OF INTRAVAGINAL DEVICE TO INCREASE WEIGHT INCREASE AND IMPROVE CARCASE QUALITY IN BOVINE FEMALES - Google Patents

USE OF INTRAVAGINAL DEVICE TO INCREASE WEIGHT INCREASE AND IMPROVE CARCASE QUALITY IN BOVINE FEMALES

Info

Publication number
UY36813A
UY36813A UY0001036813A UY36813A UY36813A UY 36813 A UY36813 A UY 36813A UY 0001036813 A UY0001036813 A UY 0001036813A UY 36813 A UY36813 A UY 36813A UY 36813 A UY36813 A UY 36813A
Authority
UY
Uruguay
Prior art keywords
increase
improve
intravaginal device
carcase quality
quality
Prior art date
Application number
UY0001036813A
Other languages
Spanish (es)
Inventor
Turic Esteban
Martinez Marisa
Original Assignee
Biogenesis Bago S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogenesis Bago S A filed Critical Biogenesis Bago S A
Publication of UY36813A publication Critical patent/UY36813A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Fodder In General (AREA)
  • Processing Of Meat And Fish (AREA)

Abstract

Esta invención provee un método para incrementar la cantidad de carne y mejorar la calidad de la carne de los bovinos hembras. En una forma de realización, el método comprende la administración de concentraciones altas de progesterona (por ej., de 2 a 5 gramos) por medio de un dispositivo intravaginal durante períodos de tiempo prolongados (por ej., de 30 a 120 días).This invention provides a method for increasing the amount of meat and improving the quality of the meat of female cattle. In one embodiment, the method comprises the administration of high concentrations of progesterone (eg, 2 to 5 grams) by means of an intravaginal device for prolonged periods of time (eg, 30 to 120 days).

UY0001036813A 2015-07-23 2016-07-22 USE OF INTRAVAGINAL DEVICE TO INCREASE WEIGHT INCREASE AND IMPROVE CARCASE QUALITY IN BOVINE FEMALES UY36813A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562196297P 2015-07-23 2015-07-23

Publications (1)

Publication Number Publication Date
UY36813A true UY36813A (en) 2017-01-31

Family

ID=57833967

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036813A UY36813A (en) 2015-07-23 2016-07-22 USE OF INTRAVAGINAL DEVICE TO INCREASE WEIGHT INCREASE AND IMPROVE CARCASE QUALITY IN BOVINE FEMALES

Country Status (4)

Country Link
AR (1) AR105311A1 (en)
BR (1) BR112017028303A2 (en)
UY (1) UY36813A (en)
WO (1) WO2017013623A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0600473A (en) * 2006-02-06 2007-10-23 Phb Ind Sa polymeric implant and its preparation process
CN101918001B (en) * 2007-12-06 2016-11-16 英特威国际有限公司 Use melengestrol acetate and zilpaterol or the therapeutic alliance of its salt

Also Published As

Publication number Publication date
AR105311A1 (en) 2017-09-27
WO2017013623A1 (en) 2017-01-26
BR112017028303A2 (en) 2018-09-04

Similar Documents

Publication Publication Date Title
DOP2019000180A (en) INHIBITORS OF TGFß1 ISOFORM-SPECIFIC CONTEXT-PERMISIVES AND USE OF THE SAME
CL2018000320A1 (en) Oil based adjuvants (application division 201600650)
CL2018002012A1 (en) Maitansinoid derivatives, conjugates thereof and methods of use.
BR112017016241A2 (en) activation target time operation triggered
PE20181004A1 (en) BISPECIFIC ANTIBODIES AGAINST HUMAN CD20 AND THE HUMAN TRANSFERRIN RECEPTOR AND METHODS OF USE
CL2021000855A1 (en) Alphavirus-based replicons for the delivery of biotherapies.
CL2020000220A1 (en) Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction.
MX2015013832A (en) Vaccine composition and method of use.
CL2020003447A1 (en) Compositions and methods for treating inflammasome-related diseases or conditions
BR112015027477A2 (en) Method for Treating a Swallowing Disorder
ECSP16026183A (en) SYSTEMS AND METHODS FOR ADJUSTING ANIMAL FEEDING
EA201790787A1 (en) REDUCTION OF VISCOSITY OF PHARMACEUTICAL COMPOSITIONS
MX364800B (en) Improved long-acting tilmicosin and use thereof in the treatment of bovine respiratory disease complex (brdc) and in the dry cow period.
CR20190220A (en) Substituted sulfonyl amides for controlling animal pests
CL2015001446A1 (en) Preparation procedure of human albumin with reduced dissolved oxygen level.
CO2020006907A2 (en) Antimicrobial peptides and methods of using them
CL2015001448A1 (en) Method for synchronization of insemination time in young sows
CL2016001098A1 (en) Use of cysteamine and its derivatives for the treatment of mitochondrial diseases
AR113514A1 (en) COMPOSITIONS AND METHODS TO IMPROVE THE USE OF PHOSPHORUS AND CALCIUM IN THE DIET OF ANIMALS
PE20161148A1 (en) SYSTEMS AND METHODS FOR INFORMATIC MODELS OF FEED FOR ANIMALS
CY1122432T1 (en) TREATMENT OF CANCER USING AN INSULIN-TYPE GROWTH FACTOR (IGF) RECEPTOR ANTAGONIST IN COMBINATION WITH EXEMESTANE AND EVEROLIME
CL2020000221A1 (en) Compositions comprising amino acids for use in the treatment of diseases related to mitochondrial dysfunction.
MX2018004296A (en) Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist.
CL2018003143A1 (en) Dihydroisoxazole compound for use in the control of sea lice
GT201300225A (en) TIENO (2,3-D) DERIVED FROM PIRIMIDINE AND ITS USE FOR THE TREATMENT OF ARRITMIA

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20230914